|
Jun 6
|
Challenges pharma companies face in push into US manufacturing
|
|
Jun 6
|
Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?
|
|
Jun 5
|
AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
|
|
Jun 5
|
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
|
|
Jun 5
|
AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?
|
|
Jun 4
|
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
|
|
Jun 4
|
3 Cheap Dividend Growth Stocks to Buy Right Now
|
|
Jun 3
|
ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons
|
|
Jun 3
|
AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals
|
|
Jun 3
|
AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
|
|
Jun 3
|
High Growth Tech Stocks To Watch In The US June 2025
|
|
May 24
|
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
|
|
May 23
|
50 Huge Companies That You’ve Never Heard of Before and Their Stock Prices
|
|
May 23
|
Key Drivers Behind AbbVie’s (ABBV) Performance
|
|
May 23
|
AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit
|
|
May 22
|
AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel
|
|
May 22
|
AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient
|
|
May 22
|
AbbVie (ABBV) has a Stable and Highly Profitable Business Model
|
|
May 22
|
3 Value Stocks Facing Headwinds
|
|
May 21
|
2 Incredible Dividend Growth Stocks to Buy Now
|